Wayne Koberstein News Today

“Moving into Phase 3 not only expands the resources you need internally, but some things require a much larger amount of capital, and often a...

Orca Bio is creating a new cell therapy aimed at bringing rebirth to stem-cell transplantation.


Kriya’s firm commitment to build or bring all key functions in house may be unusual for such a young enterprise, but it has been consistent...

Vor Bio’s story, for all of its uniqueness, can teach important lessons in many different quarters, involving everything from mundane tactics...

KaliVir Immunotherapeutics is engineering oncolytic viruses with novel transgenes, and joining them to other immunotherapies, to defeat cancer and...

Hummingbird Bioscience is joining the forces of computation and systems biology to fight cancer and autoimmune disease.


Lex Rovner founded her company with support from academic scientists and has headed it since it opened for business in 2018. At that time, she had no...

Corner Therapeutics is focused on discovering new small molecules that could mimic the body’s natural immune response to generate the robust...

Ocelot Bio is focusing a single drug on multiple complications of end-stage liver disease.


Biopharma sustainability will require the industry not shy from public opinion, but meet it head on. To win short-term battles, however impressively...